n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Adjuvant Arthritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bräuer, R; Christiansen, C; Danielsen, I; Henriksen, K; Karsdal, MA; Oestergaard, S; Qvist, P; Schurigt, U; Sondergaard, BC; Wulf, H | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Adjuvant Arthritis
| Article | Year |
|---|---|
Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
Topics: Animals; Arthritis, Experimental; Biomarkers; Cartilage, Articular; Cathepsin K; Cathepsins; Cattle; Collagen Type I; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Cytokines; Dipeptides; Extracellular Matrix; Glycosaminoglycans; Hydroxyproline; Immunohistochemistry; Leucine; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Knockout; Oncostatin M; Osteoarthritis, Knee; Peptides; Stimulation, Chemical; Tissue Culture Techniques; Tumor Necrosis Factor-alpha | 2006 |